Ting S.
Chen

Ms. Chen’s notable transactions include representing:

• Avon in its $3.7 billion acquisition by Natura

• Bacardi in its acquisition of ILEGAL Mezcal
• BDT Capital Partners in its equity investments in Tory Burch, KIND, Marquette Transportation Company and Alliance Laundry Systems

• British American Tobacco in its $97 billion merger with Reynolds American and its $4.7 billion investment in Reynolds American as part of Reynolds American’s $27.6 billion acquisition of Lorillard, as well as in Reynolds American’s related $7.1 billion sale of the KOOL, Salem, Winston, Maverick and blu eCigs brands and other assets and liabilities to Imperial Tobacco Group

• CardWorks in its acquisition of Ally’s credit card business
• DHT in an unsolicited acquisition proposal from Frontline

• DreamWorks Animation in its $4.1 billion sale to Comcast

• Genpact in connection with an approximately $1 billion investment by Bain Capital
• Global Blood Therapeutics in its $5.4 billion acquisition by Pfizer

• Honeywell in its $300 million sale of Honeywell Technology Solutions to KBR
• Horizon Blue Cross Blue Shield of New Jersey in its reorganization into a mutual holding company

• IBM in its acquisition of Accelalpha, its acquisition of assets from Spanugo, its acquisition of Armanta and the $505 million sale of its worldwide customer care business process outsourcing services business to SYNNEX

• Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL, its proxy contest against Carl Icahn and its interactions with Corvex
• InterMune in its $8.9 billion sale to Roche
• Johnson & Johnson in its $14.6 billion acquisition of Intra‑Cellular Therapies and its $2 billion acquisition of Ambrx

• KKR’s board committee in KKR’s conversion to a corporation and KKR’s $2.6 billion acquisition of KKR Financial Holdings

• Kraft in the spin‑off of its $30 billion North American grocery business and the $3.7 billion sale of its frozen pizza business to Nestlé

• Lundbeck in its acquisition of Chelsea Therapeutics for cash and contingent value rights representing a total possible consideration of $660 million
• New Senior in its $2.3 billion acquisition by Ventas

• OneBeacon Insurance and White Mountains Insurance in the $1.7 billion sale of OneBeacon Insurance to Intact Financial

• Pitney Bowes in the $700 million sale of its Software Solutions business to Syncsort, its $475 million acquisition of Newgistics and its $395 million acquisition of Borderfree

• Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement

• The Ricketts family in the $26 billion acquisition of TD Ameritrade by Charles Schwab
• Russell Stover Candies in its sale to the Lindt & Sprüngli Group
• SPANX in its sale of a majority stake to Blackstone

• Starbucks in its commercial arrangement with Oprah Winfrey to launch Oprah Chai

• Temasek in its investments in Fanatics and Virtu Financial
• Thermo Fisher Scientific in its $20.9 billion acquisition of PPD and its $3.1 billion acquisition of Olink

• The Washington Post in the $250 million sale of its newspaper publishing businesses, including The Washington Post newspaper, to Jeff Bezos

• White Mountains Insurance in the $2.6 billion sale of Sirius International Insurance to China Minsheng Investment, its and Oaktree Capital’s $250 million investment in Kudu Investment Management and its majority investment in TRANZACT

• Zale in its $1.5 billion sale to Signet Jewelers

Ms. Chen has been named a “Dealmaker of the Year” by The American Lawyer and has been recognized in IFLR1000’s “Women Leaders – United States,” The Deal’s “Top Women in Dealmaking” and Crain’s New York Business’s “Notable Women in Law.” Ms. Chen has been recognized for her work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000, The Best Lawyers in America and Lawdragon. She has also been recognized by The Legal 500 US for her activist defense work, as well as her transactional work in the media and entertainment and technology industries.

Ms. Chen regularly speaks on topics concerning corporate governance and mergers and acquisitions law. She co‑chaired a panel entitled “Developments in Public Company M&A Securities Law” hosted by the International Bar Association’s Annual International Mergers & Acquisitions Conference and has spoken multiple times at the Practising Law Institute’s (PLI) “Doing Deals: The Art of M&A Transactional Practice” program.

Ms. Chen was born in Taipei, Taiwan. She received an A.B. summa cum laude from Harvard University in 2003, where she was elected to Phi Beta Kappa, and a J.D. from Stanford Law School in 2006.

Ms. Chen joined Cravath in 2006 and was elected a partner in 2013. She currently serves as a member of the Firm’s Diversity Committee.